OracleBio data will be presented on a poster at the International Molecular Medicine TriConference, taking place in San Francisco on the 19th – 24th February. The poster, made in collaboration with Asterand Bioscience, is titled ‘Content and Spatial Distribution Analysis of PD-L1 Positive Tumor Cells and CD8 Positive T-Cells within Multiplex IHC Stained NSCLC Tumor Tissue’. […]
OracleBio data will be presented on a poster at the Experimental Biology Meeting 2017, which takes place 22nd – 26th April in Chicago. The poster is titled ‘Whole Slide Quantitative Image Analysis can Demonstrate Bleomycin Induced Dose-Dependent Increases in Fibrotic Areas Within Histologically Stained Rat Lung Tissue’ and was produced in collaboration with Charles River. The poster […]
OracleBio will be exhibiting at the 2017 American Thoracic Society (ATS) Conference, which takes place from the 19th to the 24th of May in Washington D.C. OracleBio are pleased to have data presented on two posters at the conference: ‘Quantification of Differential Fibrotic Lesions by Image Analysis in the Mouse Bleomycin Model of Pulmonary Fibrosis‘ Tuesday 23rd May, 11.15am […]
OracleBio is pleased to announce that Matthew Gaffney has recently joined the company as its Business Development Manager for the USA. Matthew is a highly skilled business development manager with previous experience working for a number of contract research organisations in the USA. Currently based in Boston, Matt’s work will focus on expanding OracleBio’s customer base in the East Coast of America. […]
A poster entitled ‘Quantification of HER3 expression in human cancer tissue by digital image analysis of mRNA in situ hybridization and immunohistochemistry’ produced by OracleBio in collaboration with Indivumed GmbH was presented at the European Organisation for Research and Treatment of Cancer (EORTC) Symposium from the 29th November to the 2nd December 2016. Click on the image below […]
OracleBio were delighted to present a poster at the Society for the Immunotherapy of Cancer (SITC) Conference, Washington DC, 11-13th Nov, 2016. The poster, entitled ‘Immune Cell Spatial Analysis on FoxP3 and CD8 Positive IHC Stained T Cells within Tumor Microenvironment’ was poster number 386 at the conference and is provided in full below. Click […]
OracleBio’s Chief Scientific Officer Lorcan Sherry and Senior Project Manager Mark Anderson will be attending the 31st Annual Meeting of the Society for Immunotherapy of Cancer (SITC). The event will take place from the 9th to the 13th of November in Washington and is known to be one of the top destinations for scientific exchange, education and […]
OracleBio is delighted to announce that Hannah Thomson has recently joined OracleBio as our Marketing Assistant. Hannah has recently completed a MSc Marketing at the University of Strathclyde and has experience in a variety of marketing roles. Prior to this, she graduated with a BSc Genetics from the University of Glasgow in 2013. Hannah […]
OracleBio will be attending the Annual Immune Checkpoint Inhibitors Europe Summit, which takes place from the 16th to the 18th of November in Munich, Germany. OracleBio offers a range of digital pathology image analysis services to support pre-clinical and clinical immuno-oncology R&D and have generated data as part of immune checkpoint inhibitor studies. In one recently […]
OracleBio is pleased to welcome two new members to the OracleBio team, Marianne Cowan and Nicole Stillie. Marianne and Nicole will be working as Image Analysis Scientists and will support OracleBio’s growing pre-clinical and clinical histopathology image analysis services. Prior to joining OracleBio, Marianne completed her PhD in Cellular and Molecular Biology at the University of […]
